Lemaitre Vascular (LMAT) Other Accumulated Expenses (2012 - 2026)

Lemaitre Vascular (LMAT) has 15 years of Other Accumulated Expenses data on file, last reported at $1.3 million in Q1 2026.

• On a quarterly basis, Other Accumulated Expenses rose 241.33% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 241.33% increase from a year earlier, with the FY2025 full-year figure at $546000.0, up 26.68% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $1.3 million, up from $546000.0 in the prior quarter.
• Over the last five years, Other Accumulated Expenses for LMAT reached as high as $6.1 million in Q2 2022 and fell as low as $119000.0 in Q3 2022.
• Historically, Other Accumulated Expenses has averaged $1.0 million across 5 years, with a median of $431000.0 in 2024.
• Across the five-year window, Other Accumulated Expenses plunged 97.78% in 2022 and soared 241.33% in 2026, its largest moves.
• Year by year, Other Accumulated Expenses stood at $252000.0 in 2022, then surged by 58.73% to $400000.0 in 2023, then advanced by 7.75% to $431000.0 in 2024, then climbed by 26.68% to $546000.0 in 2025, then jumped by 145.05% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $1.3 million in Q1 2026, $546000.0 in Q4 2025, and $438000.0 in Q3 2025.